The exploratory study for the efficacy and the safety of Rikkunshito on symptoms of indigestion in the patients with Functional Heartbur
- Conditions
- Functional Heartburn
- Registration Number
- JPRN-UMIN000029668
- Lead Sponsor
- ippon Medical School Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Not provided
1)Patients diagnosed with Eosinophilic esophagitis(EoE) 2)Patients diagnosed with Esophageal Motility disorders by High-Resolution manometry. 3)Patients who had 50% or more of Symptom Index by 24-hour Esophageal Impedance and PH monitoring. 4)Patients diagnosed with Reflux esophagitis(RE)(Los Angeles classification,>=Grade A)by upper endoscopy. 5)History of upper GI resection 6)Confirmed presence of ulcer (excluding scars) or malignant tumor in the upper GI. 7)Suspected organic hepatic/biliary/pancreatic disorders such as gallstone, hepatitis, and pancreatitis 8)History of allergic reactions to Kampo medicines. 9)Patients who were administered KAMPO medicine 4 weeks before entry. 10)Receiving or scheduled to receive an agent that is being developed. 11)Presence of serious complications (liver, kidney, heart, or blood disease or metabolic disease). 12)Pregnant or lactating women or those who are planning to conceive during the study period. 13)Considered ineligible to participate by principal investigator or sub-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.